Mechanisms underlying the activation of L-type calcium channels by urocortin in rat ventricular myocytes. (Q54689954)

2 June 2018

title

Mechanisms underlying the activation of L-type calcium channels by urocortin in rat ventricular myocytes. (English)

1 reference

2 June 2018

author

Eva Calderón-Sánchez

2

1 reference

2 June 2018

Victoria Cachofeiro

5

1 reference

2 June 2018

Antonio Ordóñez

7

1 reference

2 June 2018

Carmen Delgado

object named as

Carmen Delgado

8

0 references

Tarik Smani

object named as

Tarik Smani

1

0 references

author name string

Nieves Gómez-Hurtado

3

1 reference

2 June 2018

María Fernández-Velasco

4

1 reference

2 June 2018

Vicente Lahera

6

1 reference

2 June 2018

publication date

26 February 2010

1 reference

2 June 2018

published in

Cardiovascular Research

1 reference

2 June 2018

volume

87

1 reference

2 June 2018

issue

3

1 reference

2 June 2018

page(s)

459-466

1 reference

2 June 2018

Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

Urocortin 2 infusion in human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

Coronary vasodilation and positive inotropism by urocortin in the isolated rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

Urocortin 1 administration from onset of rapid left ventricular pacing represses progression to overt heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

Urocortin prevents mitochondrial permeability transition in response to reperfusion injury indirectly by reducing oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

The Urocortins: mechanisms of cardioprotection and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

The powerful cardioprotective effects of urocortin and the corticotropin releasing hormone (CRH) family

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

Signaling pathways in ischemic preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

Urocortin induces positive inotropic effect in rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

Calcium cycling and signaling in cardiac myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

Urocortin II enhances contractility in rabbit ventricular myocytes via CRF(2) receptor-mediated stimulation of protein kinase A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

"Run-down" of the Ca current during long whole-cell recordings in guinea pig heart cells: role of phosphorylation and intracellular calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

EF domains are sufficient for nongenomic mineralocorticoid receptor actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

Role of Ca2+-independent phospholipase A2 and store-operated pathway in urocortin-induced vasodilatation of rat coronary artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

Leukemia inhibitory factor, a potent cardiac hypertrophic cytokine, enhances L-type Ca2+ current and [Ca2+]i transient in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

cAMP acts on exchange protein activated by cAMP/cAMP-regulated guanine nucleotide exchange protein to regulate transmitter release at the crayfish neuromuscular junction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

Leukemia inhibitory factor activates cardiac L-Type Ca2+ channels via phosphorylation of serine 1829 in the rabbit Cav1.2 subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

Peptide growth factors signal differentially through protein kinase C to extracellular signal-regulated kinases in neonatal cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

ERK/MAPK regulates the Kv4.2 potassium channel by direct phosphorylation of the pore-forming subunit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

Kv4.2 is a locus for PKC and ERK/MAPK cross-talk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

A family of cAMP-binding proteins that directly activate Rap1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

The cAMP binding protein Epac regulates cardiac myofilament function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

cAMP sensor Epac as a determinant of ATP-sensitive potassium channel activity in human pancreatic beta cells and rat INS-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

Exposure to cAMP and beta-adrenergic stimulation recruits Ca(V)3 T-type channels in rat chromaffin cells through Epac cAMP-receptor proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

Protein kinase C in heart failure: a therapeutic target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVQ063

21 January 2018

Identifiers

DOI

10.1093/CVR/CVQ063

1 reference

2 June 2018

1 reference

2 June 2018